Replimune Group (REPL) reported a fiscal Q4 net loss Wednesday of $73.7 million, narrowing from a net loss of $74.1 million a year earlier.
Analysts polled by FactSet expected a net loss of $63.9 million.
As of March 31, the company said it had $268.9 million in cash, cash equivalents and short-term investments, which it said will fund operations into Q1 2027.
Shares of the company were down 2.8% in Monday premarket activity.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments